Privia Health (PRVA) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.07
- EPS estimate
- $0.07
- EPS surprise
- +3.86%
- Revenue surprise
- +5.91%
- Revenue
- $632.6M
- Revenue estimate
- $597.3M
- Reported
- Aug 6, 2026
Privia Health reported Q2 2026 results on August 6, 2026. Earnings per share were $0.07, a 3.86% beat on the $0.07 estimate. Revenue of $632.6 million beat the $597.3 million consensus by about 6%. Compared with Q2 2025, EPS rose from $0.02 and revenue grew about 21% from $521.2 million.
Annual revenue rose from $1.36 billion in 2022 to $1.66 billion in 2023, $1.74 billion in 2024 and $2.12 billion in 2025, and Q2 2026 set the high in the table. Earnings per share have stayed small. Privia lost money in the four quarters through Q2 2022, then turned profitable, with annual EPS of $0.19 in 2023, $0.11 in 2024 and $0.17 in 2025. Revenue beat estimates in 18 of 20 quarters, but Privia missed the EPS estimate in 13 of 20 quarters, including eight in a row from Q4 2023 to Q3 2025.
Privia reported Q3 between November 3 and November 10 in each of the past five years. That points to early November 2026 for the Q3 2026 report. It will show whether revenue keeps growing above 20% year over year, as it did in three of the last four quarters.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | $0.07 | $0.07 | +3.86% | $632.6M | SEC |
| Q1 2026 | May 7, 2026 | $0.07 | $0.02 | −73.30% | $603.8M | SEC |
| Q4 2025 | Feb 26, 2026 | $0.02 | $0.07 | +208.37% | $541.2M | SEC |
| Q3 2025 | Nov 6, 2025 | $0.05 | $0.05 | −8.09% | $580.4M | SEC |
| Q2 2025 | Aug 7, 2025 | $0.05 | $0.02 | −59.76% | $521.2M | SEC |
| Q1 2025 | May 8, 2025 | $0.05 | $0.03 | −34.07% | $480.1M | SEC |
| Q4 2024 | Feb 27, 2025 | $0.05 | $0.03 | −39.39% | $460.9M | SEC |
| Q3 2024 | Nov 7, 2024 | $0.05 | $0.03 | −37.11% | $437.9M | SEC |
| Q2 2024 | Aug 8, 2024 | $0.05 | $0.03 | −33.63% | $422.3M | SEC |
| Q1 2024 | May 9, 2024 | $0.05 | $0.02 | −58.07% | $415.2M | SEC |
| Q4 2023 | Feb 27, 2024 | $0.04 | $0.02 | −51.92% | $440.8M | SEC |
| Q3 2023 | Nov 3, 2023 | $0.05 | $0.05 | +1.63% | $417.3M | SEC |
| Q2 2023 | Aug 3, 2023 | $0.06 | $0.06 | +7.14% | $413.4M | SEC |
| Q1 2023 | May 4, 2023 | $0.06 | $0.06 | −2.44% | $386.3M | SEC |
| Q4 2022 | Feb 28, 2023 | $0.01 | $0.14 | +1057.02% | $364.4M | SEC |
| Q3 2022 | Nov 10, 2022 | $0.02 | $0.01 | −52.15% | $342.9M | SEC |
| Q2 2022 | Aug 11, 2022 | $0.00 | −$0.10 | −5100.00% | $335.5M | SEC |
| Q1 2022 | May 12, 2022 | −$0.01 | −$0.16 | −1255.93% | $313.8M | SEC |
| Q4 2021 | Mar 22, 2022 | −$0.13 | −$0.11 | +12.97% | $275.3M | SEC |
| Q3 2021 | Nov 8, 2021 | −$0.14 | −$0.09 | +33.33% | $251.5M | SEC |
Quarterly revenue
Frequently asked questions
When did Privia Health (PRVA) last report earnings?
Privia Health last reported on Aug 6, 2026, covering fiscal Q2 2026.
Did PRVA beat earnings estimates?
Yes. Privia Health reported EPS of $0.07 for Q2 2026 against a $0.07 estimate — a 3.86% beat.
How much revenue did PRVA report last quarter?
Privia Health reported $632.6M in revenue for Q2 2026, against a consensus estimate of $597.3M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.